Amryt Pharma plc (AMYT) Income Annual - Discounting Cash Flows
AMYT
Amryt Pharma plc
AMYT (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
03-31
2014
03-31
2013
03-31
2012
03-31
2011
03-31
2010
03-31
2009
03-31
2008
03-31
2007
12-31
Report Filing 2022-09-30 2022-04-29 2021-04-30 2019-12-31 2018-12-31 2017-12-31 2016-12-31 2015-03-31 2014-03-31 2013-03-31 2012-03-31 2011-03-31 2010-03-31 2009-03-31 2008-03-31 2007-12-31
Revenue 243.6 222.5 182.6 58.12 16.53 15.33 1.42 0 0 0 0 0 0 0 0 0
Cost of Revenue 127 106.1 119 42 6.06 6.45 0.616 0 0 0 0 0 0 0 0 0
Gross Profit 116.6 116.4 63.58 16.12 10.47 8.88 0.805 0 0 0 0 0 0 0 0 0
Operating Expenses 161.7 138.1 109 52.17 27.92 25.93 8.88 39.93 2.93 2.93 0.275 0.275 0.281 0.46 3.28 2.43
Research & Development 37.83 37.73 27.62 15.83 10.35 12.67 2.46 0 0 0 0 0 0 0 0 0
Selling, General and Administrative 123.8 100.3 76.67 36.34 17.57 13.25 4.25 3.33 3.33 1.87 1.87 0.281 0.281 1.75 1.75 3.05
Other Operating Expenses 0 0 4.73 0 0.001 0 2.17 36.6 -0.392 1.07 -1.59 -0.006 -0 -1.28 1.53 -0.624
Operating Income -45.08 -21.64 -45.44 -36.04 -17.45 -17.04 -8.08 -39.93 -2.93 -2.93 -0.275 -0.275 -0.281 -0.46 -3.28 -2.43
Net Non-Operating Interest -31.99 -27.9 -19.48 -8.39 -1.78 -0.984 -0.126 0.185 0.201 0.319 0 0 0 0 0 0
Interest Income 0 0.005 0.087 0.092 0.006 0.006 0.001 0.185 0.201 0.319 0 0 0 0 0 0
Interest Expense 31.99 27.91 19.57 8.48 1.78 0.99 0.127 0 0 0 0 0 0 0 0 0
Equity & Other Income/(Expense) 52.45 19.73 -40.94 -22.33 -10.22 -13.33 -0.001 0.004 -37.01 0.496 -1.84 -0.006 0 -0.063 0.008 0.014
Income Before Tax -24.61 -29.81 -105.9 -66.76 -29.45 -31.36 -8.21 -39.74 -39.74 -2.12 -2.12 -0.281 -0.281 -0.523 -3.27 -2.41
Income Tax Expense -4.65 -11.64 -1.33 -1.23 0.041 14.31 0 0 -0.175 2.23 0.551 2.68 0.002 -0.026 0 0
Income Attributable to Non-Controlling Interest 0 0 0 0 -0 0.001 0 0 -37.01 -2.23 -1.84 0.1 -0.159 -0 0 0
Net Income -19.96 -18.17 -104.5 -65.53 -29.49 -45.67 -8.21 -39.74 -2.56 -2.12 -0.826 -3.06 -0.124 -0.497 -3.27 -2.41
Depreciation and Amortization 11.43 50.74 44.47 12.63 0.355 0.311 0.204 0.006 0.006 0.005 0.005 0.1 0.1 0.145 0.145 0.161
EBITDA -33.65 29.1 -0.977 -23.42 -17.09 -16.73 -7.88 -39.92 -2.93 -2.93 -0.27 -0.175 -0.181 -0.315 -3.13 -2.27
Earnings Per Share (EPS) -0.31 -0.39 -2.92 -4.32 -3.22 -6.14 -1.51 -3.45 -0.26 -0.26 -0.082 -0.3 -0.012 -0.052 -0.42 -0.42
Diluted Earnings Per Share -0.31 -0.37 -2.92 -4.32 -3.22 -6.14 -1.51 -3.45 -0.26 -0.26 -0.082 -0.3 -0.012 -0.052 -0.42 -0.42
Weighted Average Shares Outstanding 64.05 47.17 35.76 15.17 9.16 7.44 5.45 11.51 9.81 6.47 6.47 10.12 10.12 10.12 9.59 7.87
Diluted Weighted Average Shares Outstanding 64.05 49.4 35.76 15.17 9.16 7.44 5.45 11.51 9.81 6.47 6.47 10.12 10.12 10.12 9.59 7.87
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program